Long-term impact of androgen-deprivation therapy on physical function and quality of life

Cancer

Volumn 121, Issue 14, 2015, Pages 2350-2357

  Alibhai, Shabbir M H ^a,b,c   Breunis, Henriette ^a   Timilshina, Narhari ^a   Naglie, Gary ^b,c,d   Tannock, Ian ^a,b   Krahn, Murray ^a,b,c   Warde, Padraig ^b   Fleshner, Neil E ^e   Canning, Sarah Duff ^a   Tomlinson, George ^a,b,c,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

activities of daily living; androgen deprivation therapy; physical function; prospective study; prostate carcinoma; quality of life

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT;

AGED; CASE CONTROL STUDY; DRUG ADMINISTRATION; HAND STRENGTH; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRE; TASK PERFORMANCE; VERY ELDERLY; WALKING;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; HAND STRENGTH; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; TASK PERFORMANCE AND ANALYSIS; WALKING;

EID: 84934344042     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29355     Document Type: Article

References (30)

1. Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR,. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology. 2002; 60: 7-11.
2. Nguyen PL, Alibhai SM, Basaria S, et al., Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. 2015; 67: 825-836.
3. Alibhai SMH, Breunis H, Timilshina N, et al., Impact of androgen-deprivation therapy on physical function and quality of life in men with non-metastatic prostate cancer. J Clin Oncol. 2010; 28: 5038-5045.
4. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR,. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology. 1999; 53: 180-186.
5. Herr HW, O'Sullivan M,. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol. 2000; 163: 1743-1746.
6. Lubeck DP, Grossfeld GD, Carroll PR,. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology. 2001; 58: 94-100.
7. Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL,. Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther. 2007; 87: 1325-1333.
8. Leveille SG, Guralnik JM, Ferrucci L, Langlois JA,. Aging successfully until death in old age: opportunities for increasing active life expectancy. Am J Epidemiol. 1999; 149: 654-664.
9. Ling CH, Taekema D, de Craen AJ, Gussekloo J, Westendorp RG, Maier AB,. Handgrip strength and mortality in the oldest old population: the Leiden 85-Plus Study. CMAJ. 2010; 182: 429-435.
10. Gardner JR, Livingston PM, Fraser SF,. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014; 32: 335-346.
11. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM,. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005; 23: 5814-5830.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
13. Solway S, Brooks D, Lacasse Y, Thomas S,. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001; 119: 256-270.
14. Enright PL, McBurnie MA, Bittner V, et al., The 6-min walk test: a quick measure of functional status in elderly adults. Chest. 2003; 123: 387-398.
15. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM,. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003; 51: 636-641.
16. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S,. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil. 1985; 66: 69-74.
17. Podsiadlo D, Richardson S,. The timed Up & Go: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39: 142-148.
18. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB,. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995; 332: 556-561.
19. Ware J, Sherbourne C,. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care. 1992; 30: 473-483.
20. Mahoney FI, Barthel DW,. Functional evaluation: the Barthel index. Md State Med J. 1965; 14: 61-65.
21. Lawton MP, Brody EM,. Assessment of older people: self-maintaining and instrument activities of daily living. Gerontologist. 1969; 9: 179-186.
22. Yesavage JA, Brink TL, Rose TL, et al., Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res. 1982; 17: 37-49.
23. Ware JE Jr, Kosinski M, Keller SD,. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: Health Institute; 1994.
24. Rothman KJ,. No adjustments are needed for multiple comparisons. Epidemiology. 1990; 1: 43-46.
25. Osoba D, Bezjak A, Brundage M, Zee B, Tu D, Pater J,. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada Clinical Trials Group. Eur J Cancer. 2005; 41: 280-287.
26. Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W,. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer. 2011; 117: 4406-4413.
27. Cesari M, Kritchevsky SB, Newman AB, et al., Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2009; 57: 251-259.
28. Sawhney R, Sehl M, Naeim A,. Physiologic aspects of aging: impact on cancer management and decision making, part I. Cancer J. 2005; 11: 449-460.
29. Sehl M, Sawhney R, Naeim A,. Physiologic aspects of aging: impact on cancer management and decision making, part II. Cancer J. 2005; 11: 461-473.
30. Niraula S, Le LW, Tannock IF,. Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trials. J Clin Oncol. 2013; 31: 2029-2036.